Skip to Main Content

Julio C. Rojas

MD PhD

Neurologist
Physician and clinical neuroscientist

Dr. Julio C. Rojas is a neurologist who specializes in dementia, caring for patients with cognitive difficulties or behavioral changes resulting from conditions including Alzheimer's disease, Lewy body dementia (a form of dementia that causes cognitive defects and Parkinson's-like symptoms), frontotemporal dementia (a common cause of dementia in younger adults that features behavioral changes) and progressive supranuclear palsy (a condition affecting movement and behavior in older adults). With particular expertise in managing difficult behaviors in dementia, he creates care plans to equip patients and their families with the necessary tools for achieving their best-possible quality of life.

In his research, Rojas looks for blood tests that could be used to diagnose dementia. He also works on developing novel treatments to prevent or slow neurological degeneration and cognitive impairment. His research is funded by the National Institute on Aging.

Rojas earned his medical degree from the School of Medicine and Health Sciences of the Tecnológico de Monterrey in Mexico. He earned a doctorate in neuroscience from the University of Texas at Austin. He completed a residency in neurology at the University of Texas Southwestern Medical Center and a fellowship in behavioral neurology at UCSF.

A native of Mexico City, Rojas conducts patient evaluations in both English and Spanish. He strives to improve access to dementia care for Hispanic communities in the United States. For the UCSF Memory and Aging Center, he co-chairs a task force that works to improve management of behavioral symptoms for the center's patients with dementia. He also participates in UCSF committees on ethics and on diversity and inclusion.

  • Education

    School of Medicine and Health Sciences, Tecnológico de Monterrey, MD, 2003

  • Residencies

    UT Southwestern Medical Center, Neurology, 2014

  • Fellowships

    UCSF, Behavioral Neurology, 2017

  • Academic Title

    Associate Professor

  • Languages

    Spanish

The brain is the most fascinating piece of organized matter in the universe. Your brain is unique. We can help you care for it. You are not alone.

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    44 Ratings
    About our process
    Jun 22, 2024
    The physician tool his time and explained everything.
    Apr 29, 2024
    Dr. Rojas-Martinez is very compassionate and kind. I deeply value his attentive approach to actively listening to my concerns.
    Apr 28, 2024
    Dr. Rojas is an exceptional physician and we trust him wholeheartedly We could not ask ask for a more competent and caring doctor.
    Apr 27, 2024
    Dr Rojas is caring, gentle, listen well and give good suggestions!
    Apr 01, 2024
    Excellent doctor. Been with 10 years including in person, in research, zoom meets.
    Dec 07, 2023
    We could not be any happier with Dr. Rojas. He is outstanding!!
    Oct 24, 2023
    Dr. Rojas is very knowledgeable and compassionate.
    Oct 23, 2023
    Excelent Physichan
    Jun 17, 2023
    Dr Rojos listens to me and my concerns
    May 23, 2023
    Great!
    May 15, 2023
    Excellent service
    Feb 18, 2023
    The care provider was awesome
    Jan 30, 2023
    Not sure how to go about finding a speech therapist, and not sure where to look for in-home care. (after visit summary do not have the info)
    Dec 17, 2022
    I'm very happy with the care provider, his manners, how well he listened to my concerns and how we came to his recommendations of my "treatment" together.
    Oct 30, 2022
    We did not have time to go over some questions but the provider offered to have a phone visit which I will ask for. So very good
    Decorative Caduceus

    AMX0035 and Progressive Supranuclear Palsy

    Assess the impact of AMX0035 on disease progression as measured by the Progressive Supranuclear Palsy (PSP) Rating Scale (PSPRS); Total scores range from 0-96 with higher scores indicating more progressed disease

    Recruiting

    Share